Back to search

Peptide record

TPDB41381

ES-2 Anticancer standard
11 amino acids
Basic Information
3D PDB MODEL
Drag to rotate. Click a residue or atom to inspect it; the selected residue is highlighted in amber.
TPDB41381
ES-2
Anticancer
Cancer-related peptides
AntiCP 2.0 CancerPPD 2.0 Peptipedia SATPdb dbACP iACP-DRLF
standard
No
A 11-aa standard natural anticancer peptide sequence curated from AntiCP 2.0, CancerPPD 2.0, Peptipedia, and other sources, with an available 3D structural model.
Sequence
IVRRADRAAVP
Physicochemical Analysis
C52H94N20O14
NCEQGHLKMFSTWY
AR
1223.44
12.10
3
1
6
+2
3.43
-0.027
115.45
Mammalian: 20 hour Yeast: 30 min E.coli: >10 hour
0
0.00
0
Residue Composition
number
3
A
3
R
0
N
1
D
0
C
0
E
0
Q
0
G
0
H
1
I
0
L
0
K
0
M
0
F
1
P
0
S
0
T
0
W
0
Y
2
V
Amino Acid Distribution
A: 3 R: 3 N: 0 D: 1 C: 0 E: 0 Q: 0 G: 0 H: 0 I: 1 L: 0 K: 0 M: 0 F: 0 P: 1 S: 0 T: 0 W: 0 Y: 0 V: 2
Chemical Descriptors
11
C52H94N20O14
1223.44
12.10
+2
3.43
-0.027
Free
L
Linear
Free
Antitumor
Endostatin derived synthetic peptide
Evidence Records 3 records
Evidence 1 Activity

Activity

60% inhibition at 2.5µg/ml
Anticancer

Target

Tumor
BAE
Not Available

Assay & Model

MTT/MTS assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2010

Other

Source Activity Label Source Definition
Anticancer
CancerPPD 2.0 manually curated experimentally verified anticancer peptide/protein annotation.
Evidence 2 Activity

Activity

60% inhibition at 5µg/ml
Anticancer

Target

Tumor
BAE
Not Available

Assay & Model

MTT/MTS assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2010
Evidence 3 Activity

Activity

60% inhibition at 10µg/ml
Anticancer

Target

Tumor
BAE
Not Available

Assay & Model

MTT/MTS assay

Source & Reference

CancerPPD 2.0 dbACP SATPdb
CancerPPD2
2010